Loading clinical trials...
Loading clinical trials...
Observational Post-authorization Prospective Study to Characterize the Incidence of Epidermal Growth Factor Receptor (EGFR) Mutation Positive and Advanced Non-small Cell Lung Cancer Patients and Their Clinical Management in Galicia
Conditions
Locations
9
Spain
Centro Oncologico de Galicia
A Coruña, A Coruña, Spain
Complexo Hospitalario Arquitecto Marcide
Ferrol, A Coruña, Spain
Hospital Clínico Universitario de Santiago de Compostela
Santiago de Compostela, A Coruña, Spain
Lucus Augusti Hospital
Lugo, Lugo, Spain
Complejo Hospitalario de Ourense
Ourense, Orense, Spain
Complexo Hospitalario de Pontevedra
Pontevedra, Pontevedra, Spain
Start Date
March 1, 2011
Primary Completion Date
December 1, 2012
Completion Date
February 1, 2013
Last Updated
November 6, 2012
Lead Sponsor
Grupo Gallego de Cancer de Pulmon
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions